Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asal Rahimi

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Kent A Griffith, Eleanor E Harris, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
JAMA Network Open|November 14, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical TrialAsal Rahimi, Marilyn Leitch, Basak Dogan, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Kent A Griffith, Eleanor E Harris, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
JAMA Network Open|November 14, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical TrialAsal Rahimi, Marilyn Leitch, Basak Dogan, et al.
Pageof 6